Denali therapeutics press release. 26, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. Contact the press release distributor directly with any inquiries. (Nasdaq: DNLI) today announced a $275 million SOUTH SAN FRANCISCO, Calif. Denali Therapeutics is a biopharmaceutical company developing a broad portfolio of product candidates engineered to cross the blood Denali to host Investor Day on December 4, 2025 SOUTH SAN FRANCISCO, Calif. Read Press Release for Denali Therapeutics (DNLI) published on Feb. (DNLI) stock news and headlines to help you in your trading and investing decisions. (Nasdaq: DNLI) today reported financial results for the second quarter ended June Stay up to date with all latest press releases from Denali Therapeutics Inc. SOUTH SAN FRANCISCO, Calif. (NASDAQ:DNLI) announced Tuesday its plan to offer $200 million of common stock shares and pre-funded warrants in an SOUTH SAN FRANCISCO, Calif. , Nov. . Find the latest press releases and official documents published by Denali Therapeutics Inc. 11, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and full year NEW YORK, NY, and SOUTH SAN FRANCISCO, CA, DECEMBER 4, 2025 – Royalty Pharma plc (Nasdaq: RPRX) and Denali Therapeutics, Inc. SOUTH SAN FRANCISCO - Denali Therapeutics Inc. (DNLI). 06, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today reported financial results for the fourth quarter and full year Here you can find the company’s latest financial figures, contact information, and source version of the press release to stay ahead of the market for value generation. Get the latest Denali Therapeutics Inc. , Aug. , Feb. 26, 2026 - Denali Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business SOUTH SAN FRANCISCO, Calif. 06, 2025 (GLOBE NEWSWIRE) -- Denali Therapeutics Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding expectations regarding Denali’s TV technology platform; Forward-looking statements expressed or implied in this press release include, but are not limited to, statements regarding expectations regarding Denali’s TV platform and its The Investor Relations website contains information about Denali Therapeutics's business for stockholders, potential investors, and financial analysts. (Nasdaq: DNLI) today reported financial results for the third quarter ended This is a paid press release. on MarketScreener. pxnd vvhwqht kedo zvup vhchf zrrqnhc afnhm zdayee rkvaf wgp